Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies - 18/06/18
Doi : 10.1016/j.jaad.2018.01.003
Jorge R. Georgakopoulos, BSc a, Michelle Phung, BMSc b, Arvin Ighani, BMSc c, Jensen Yeung, MD, FRCPC c, d, e, f, ⁎ 
a Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada
b Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
c Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
d Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
e Women's College Hospital, Toronto, Ontario, Canada
f Probity Medical Research Inc, Waterloo, Ontario, Canada
∗Correspondence to: Jensen Yeung, MD, FRCPC, Department of Dermatology, Women's College Hospital, 76 Grenville St, Fifth Floor, Toronto, Ontario, Canada, M5S 1B2Department of DermatologyWomen's College Hospital76 Grenville St, Fifth FloorTorontoOntarioM5S 1B2Canada
| Funding sources: None. |
|
| Conflicts of interest: Dr Yeung has been a speaker, consultant, and investigator for AbbVie, Allergan, Amgen, Astellas, Boehringer Ingelheim, Celgene, Centocor, Coherus, Dermira, Eli Lilly, Forward, Galderma, Janssen, Leo, Medimmune, Merck, Novartis, Pfizer, Regeneron, and Takeda. Mr Georgakopoulos, Ms Phung, and Mr Ighani have no conflicts of interest to disclose. |
|
| Previously presented: Data from this report was previously presented at Psoriasis Gene to Clinic, 8th International Congress, in London, England, November 30-December 2, 2017. |
|
| Reprints not available from the author(s). |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 79 - N° 1
P. 155-157 - juillet 2018 Retour au numéro
Article précédent
- Malignancy-associated dermatomyositis: Retrospective case–control study from a single tertiary care center
- Laura Kooistra, Claudia Ricotti, Fabrizio Galimberti, Carmen Gota, Anthony P. Fernandez
- Dermatology faculty and residents' perspectives on the dermatology residency application process: A nationwide survey
- Nathan W. Rojek, Kanade Shinkai, Nicole Fett
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?